Article
Envision Pharma Group
Why Chasing Titles is Fools Gold
Summary
In this episode, Tom Caravela welcomes Archie Stone, VP of Product Development at Aurinia Pharmaceuticals, to discuss the intricacies of titles in medical affairs. They explore the variability and experience discrepancies in titles across the industry, emphasizing the importance of focusing on skills for career advancement. Archie shares insights on the benefits of senior-level titles and uses a rock climbing analogy to illustrate career progression and skill development. The conversation also addresses skill gaps, common career progression mistakes, and the versatility required for successful company transitions. The episode concludes with valuable advice for medical affairs leaders and expressions of gratitude to the listeners.
Archie Stone, Vice President Product Development at Aurinia Pharmaceuticals discusses career development strategies and why chasing titles can lead to "fools gold".
Learn more about…
๐ The importance of titles in medical affairs
๐ How companies determine titles and levels
๐ The universal standard for titles and levels (or lack thereof)
๐ Why rock climbing is a good analogy for career progression
๐ Common mistakes people are making in their careers
๐ Advice for job seekers to find career success
medical affairs, career development, title variability, skill advancement, career progression
Related Topics
You May Also Like
Envision Pharma Group
Article
Envision Pharma Group
Medical affairs: The power behind redefining commercialization
Podcast
MSL Talk: Tom Caravela, Carsten Schnatwinkel, Jeanna Cooper
The Struggle With KOL Access in Todays World
Podcast
MSL Talk: Tom Caravela, Daniel Snyder
Interim Impact The Rise of Fractional Medical Affairs Roles in Pharmas New Reality
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois